Correlation Between 58013MEU4 and Inhibrx
Specify exactly 2 symbols:
By analyzing existing cross correlation between MCDONALDS P MEDIUM and Inhibrx, you can compare the effects of market volatilities on 58013MEU4 and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 58013MEU4 with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of 58013MEU4 and Inhibrx.
Diversification Opportunities for 58013MEU4 and Inhibrx
Very weak diversification
The 3 months correlation between 58013MEU4 and Inhibrx is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding MCDONALDS P MEDIUM and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and 58013MEU4 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MCDONALDS P MEDIUM are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of 58013MEU4 i.e., 58013MEU4 and Inhibrx go up and down completely randomly.
Pair Corralation between 58013MEU4 and Inhibrx
Assuming the 90 days trading horizon MCDONALDS P MEDIUM is expected to under-perform the Inhibrx. But the bond apears to be less risky and, when comparing its historical volatility, MCDONALDS P MEDIUM is 17.09 times less risky than Inhibrx. The bond trades about -0.03 of its potential returns per unit of risk. The Inhibrx is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,244 in Inhibrx on November 3, 2024 and sell it today you would earn a total of 114.00 from holding Inhibrx or generate 9.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.2% |
| Values | Daily Returns |
MCDONALDS P MEDIUM vs. Inhibrx
Performance |
| Timeline |
| MCDONALDS P MEDIUM |
| Inhibrx |
58013MEU4 and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 58013MEU4 and Inhibrx
The main advantage of trading using opposite 58013MEU4 and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 58013MEU4 position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| 58013MEU4 vs. AEP TEX INC | 58013MEU4 vs. US BANK NATIONAL | 58013MEU4 vs. Valley National Bancorp | 58013MEU4 vs. LightPath Technologies |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |